Clinical Trial Update: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the efficacy and safety of orally administered engineered probiotic CBT102-A in children with phenylketonuria; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• CBT102-A

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Phenylketonuria | EARLY_Phase 1 | Status: COMPLETED